Dogwood Therapeutics, Inc.
DWTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,559 | $10,800 | $2,613 | $42,606 |
| - Cash | $14,848 | $3,317 | $7,031 | $14,008 |
| + Debt | $15,586 | $0 | $0 | $0 |
| Enterprise Value | $3,297 | $7,483 | -$4,418 | $28,598 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$12,246 | -$5,447 | -$12,315 | -$15,641 |
| % Margin | – | – | – | – |
| Net Income | -$12,350 | -$5,296 | -$12,248 | -$15,960 |
| % Margin | – | – | – | – |
| EPS Diluted | -12.52 | -7.05 | -27.66 | -47.9 |
| % Growth | -77.6% | 74.5% | 42.3% | – |
| Operating Cash Flow | -$8,791 | -$4,870 | -$11,468 | -$15,690 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$8,791 | -$4,870 | -$11,468 | -$15,690 |